Literature DB >> 5133814

Withdrawal of antiparkinson drugs.

P Orlov, G Kasparian, A DiMascio, J O Cole.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 5133814     DOI： 10.1001/archpsyc.1971.01750170026005

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN： 0003-990X


× No keyword cloud information.
  9 in total

1.  Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortiacal systems.

Authors:  B Scatton; A Boireau; C Garret; J Glowinski; L Julou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-01       Impact factor: 3.000

2.  Adequate individualized dosages (AID) in perspective.

Authors:  J C Maerz
Journal:  Proc R Soc Med       Date:  1976

3.  Efficient management of the acute psychotic patient: stabilization and maintenance with haloperidol.

Authors:  P E Garfinkel
Journal:  Proc R Soc Med       Date:  1976

4.  A brief update in psychopharmacology.

Authors:  M S Rapp
Journal:  Can Fam Physician       Date:  1979-03       Impact factor: 3.275

Review 5.  Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs.

Authors:  L E Hollister
Journal:  Drugs       Date:  1972       Impact factor: 9.546

6.  Adverse effects of antipsychotic agents.

Authors:  G M Simpson; E H Pi; J J Sramek
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

7.  Rehabilitation of the chronic patient: experience in the USA.

Authors:  J S Howard
Journal:  Proc R Soc Med       Date:  1976

8.  Anticholinergic drug abuse: a common problem?

Authors:  G P Pullen; N R Best; J Maguire
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-08

9.  A study of prophylactic value of antiparkinsonian drug.

Authors:  P B Behere; P Ramakrishna
Journal:  Indian J Psychiatry       Date:  1983-07       Impact factor: 1.759
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.